These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
655 related articles for article (PubMed ID: 3419425)
1. Antibodies to a synthetic peptide can be used to distinguish between muscarinic acetylcholine receptor binding sites in brain and heart. Luthin GR; Harkness J; Artymyshyn RP; Wolfe BB Mol Pharmacol; 1988 Sep; 34(3):327-33. PubMed ID: 3419425 [TBL] [Abstract][Full Text] [Related]
2. Differential ontogeny of putative M1 and M2 muscarinic receptor binding sites in the murine cerebral cortex and heart. Evans RA; Watson M; Yamamura HI; Roeske WR J Pharmacol Exp Ther; 1985 Dec; 235(3):612-8. PubMed ID: 3841156 [TBL] [Abstract][Full Text] [Related]
3. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. II. Characterization and regulation of antagonist binding to putative muscarinic subtypes. Watson M; Roeske WR; Yamamura HI J Pharmacol Exp Ther; 1986 May; 237(2):419-27. PubMed ID: 3754581 [TBL] [Abstract][Full Text] [Related]
4. Regulation of muscarinic receptor subtypes and their responsiveness in rat brain following chronic atropine administration. Lee W; Wolfe BB Mol Pharmacol; 1989 Nov; 36(5):749-57. PubMed ID: 2555673 [TBL] [Abstract][Full Text] [Related]
5. Characterization of [3H]pirenzepine binding to muscarinic cholinergic receptors solubilized from rat brain. Luthin GR; Wolfe BB J Pharmacol Exp Ther; 1985 Jul; 234(1):37-44. PubMed ID: 3839265 [TBL] [Abstract][Full Text] [Related]
6. Cholinergic innervation and topographical organization of muscarinic binding sites in rat brain: a comparative autoradiographic study. Tonnaer JA; Ernste BH; Wester J; Kelder K J Chem Neuroanat; 1988; 1(2):95-110. PubMed ID: 3267343 [TBL] [Abstract][Full Text] [Related]
7. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. I. Characterization and regulation of agonist binding to putative muscarinic subtypes. Watson M; Yamamura HI; Roeske WR J Pharmacol Exp Ther; 1986 May; 237(2):411-8. PubMed ID: 3754580 [TBL] [Abstract][Full Text] [Related]
8. Comparison of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to muscarinic cholinergic receptors in rat brain. Luthin GR; Wolfe BB J Pharmacol Exp Ther; 1984 Mar; 228(3):648-55. PubMed ID: 6546770 [TBL] [Abstract][Full Text] [Related]
9. Muscarinic cholinergic receptor binding sites differentiated by their affinity for pirenzepine do not interconvert. Gil DW; Wolfe BB J Pharmacol Exp Ther; 1986 May; 237(2):577-82. PubMed ID: 3009794 [TBL] [Abstract][Full Text] [Related]
10. Gallamine binding to muscarinic M1 and M2 receptors, studied by inhibition of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to rat brain membranes. Burke RE Mol Pharmacol; 1986 Jul; 30(1):58-68. PubMed ID: 3755217 [TBL] [Abstract][Full Text] [Related]
11. Development of an antiserum against m3 muscarinic receptors: distribution of m3 receptors in rat tissues and clonal cell lines. Wall SJ; Yasuda RP; Li M; Wolfe BB Mol Pharmacol; 1991 Nov; 40(5):783-9. PubMed ID: 1944243 [TBL] [Abstract][Full Text] [Related]
12. Muscarinic receptor subtypes in human nasal mucosa: characterization, autoradiographic localization, and function in vitro. Okayama M; Mullol J; Baraniuk JN; Hausfeld JN; Feldman B; Merida M; Shelhamer JH; Kaliner MA Am J Respir Cell Mol Biol; 1993 Feb; 8(2):176-87. PubMed ID: 8427708 [TBL] [Abstract][Full Text] [Related]
14. Irreversible and quaternary muscarinic antagonists discriminate multiple muscarinic receptor binding sites in rat brain. Norman AB; Eubanks JH; Creese I J Pharmacol Exp Ther; 1989 Mar; 248(3):1116-22. PubMed ID: 2703964 [TBL] [Abstract][Full Text] [Related]
15. Subtype-specific antibodies for muscarinic cholinergic receptors. I. Characterization using transfected cells and avian and mammalian cardiac membranes. Mayanil CS; Richardson RM; Hosey MM Mol Pharmacol; 1991 Dec; 40(6):900-7. PubMed ID: 1758441 [TBL] [Abstract][Full Text] [Related]
16. Thermodynamic analyses of pirenzepine binding to membrane-bound and solubilized muscarinic receptors from rat forebrain and heart. Mei L; Wang JX; Roeske WR; Yamamura HI J Pharmacol Exp Ther; 1987 Sep; 242(3):991-1000. PubMed ID: 3656121 [TBL] [Abstract][Full Text] [Related]
17. Development of antisera selective for m4 and m5 muscarinic cholinergic receptors: distribution of m4 and m5 receptors in rat brain. Yasuda RP; Ciesla W; Flores LR; Wall SJ; Li M; Satkus SA; Weisstein JS; Spagnola BV; Wolfe BB Mol Pharmacol; 1993 Feb; 43(2):149-57. PubMed ID: 8429821 [TBL] [Abstract][Full Text] [Related]
18. Distinct kinetic binding properties of N-[3H]-methylscopolamine afford differential labeling and localization of M1, M2, and M3 muscarinic receptor subtypes in primate brain. Flynn DD; Mash DC Synapse; 1993 Aug; 14(4):283-96. PubMed ID: 8248852 [TBL] [Abstract][Full Text] [Related]
19. Solubilization with digitonin alters the kinetics of pirenzepine binding to muscarinic receptors from rat forebrain and heart. Wang JX; Mei L; Yamamura HI; Roeske WR J Pharmacol Exp Ther; 1987 Sep; 242(3):981-90. PubMed ID: 3116203 [TBL] [Abstract][Full Text] [Related]